Vetbiolix
PrivateLast Round
Series A
Dec 2, 2024
Total Funding Raised
$6.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vetbiolix is a biotechnology company that develops innovative prescription medicines and care products for the treatment and prevention of diseases affecting pets, focusing on periodontitis, osteoarthritis, and gut motility disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetbiolix Comparables
Compare Vetbiolix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Okava Pharmaceuticals | 84% | |
| Vetigenics Inc. | 79% | |
| Vetbiobank | 78% | |
Vetbiolix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 2, 2024 | ||||
| Seed | Sep 12, 2022 |
Vetbiolix Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors increased 219% MoM, reaching 1.7K.
- May 16, 2026
Monthly visitors grew 124% MoM, from 241 to 541.
Vetbiolix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vetbiolix's valuation, stock price, and market status.